Next Article in Journal
Ultrasound Imaging for Diaphragm Function in a Population of Healthy Infants: A Short Observational Report
Previous Article in Journal
DDPM: A Dengue Disease Prediction and Diagnosis Model Using Sentiment Analysis and Machine Learning Algorithms
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Impact of a Positive Biofire® FilmArray® Gastrointestinal Panel Result on Clinical Management and Outcomes

1
Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel
2
The Clinical Microbiology Laboratory, Tzafon Medical Center, Poriya, Tiberias 1528001, Israel
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Diagnostics 2023, 13(6), 1094; https://doi.org/10.3390/diagnostics13061094
Submission received: 7 February 2023 / Revised: 2 March 2023 / Accepted: 10 March 2023 / Published: 14 March 2023
(This article belongs to the Section Diagnostic Microbiology and Infectious Disease)

Abstract

The gold standard diagnostic method for gastrointestinal infections is stool culture, which has limited sensitivity and long turnaround time. Infection diagnosis recently shifted to syndrome-based panel assays. This study employed the FilmArray® Gastrointestinal Panel, which detects 22 pathogens simultaneously, to investigate gastrointestinal infection and pathogen distribution in 91 stool samples of patients hospitalized at the Tzafon Medical Center, Israel, during 2020, and to compare the clinical and demographic data of negative vs. positive samples. Among the 61 positive samples (67%), the most common pathogen was Campylobacter (34.4%). Positive test results were associated with a slightly younger patient age (p = 0.012), significantly higher post-diagnosis use of antibiotics (63.9% vs. 36.7%; p = 0.014), and shorter length of stay and time to discharge (p = 0.035, p = 0.003, respectively) than negative test results. To conclude, the FilmArray® Gastrointestinal Panel enabled the early identification of causative infectious agents and enhanced clinical management and outcomes.
Keywords: gastrointestinal infections; FilmArray® Gastrointestinal Panel; pathogen distribution; positive result; clinical management and outcomes gastrointestinal infections; FilmArray® Gastrointestinal Panel; pathogen distribution; positive result; clinical management and outcomes

Share and Cite

MDPI and ACS Style

Carmon, D.; Rohana, H.; Azrad, M.; Peretz, A. The Impact of a Positive Biofire® FilmArray® Gastrointestinal Panel Result on Clinical Management and Outcomes. Diagnostics 2023, 13, 1094. https://doi.org/10.3390/diagnostics13061094

AMA Style

Carmon D, Rohana H, Azrad M, Peretz A. The Impact of a Positive Biofire® FilmArray® Gastrointestinal Panel Result on Clinical Management and Outcomes. Diagnostics. 2023; 13(6):1094. https://doi.org/10.3390/diagnostics13061094

Chicago/Turabian Style

Carmon, David, Hanan Rohana, Maya Azrad, and Avi Peretz. 2023. "The Impact of a Positive Biofire® FilmArray® Gastrointestinal Panel Result on Clinical Management and Outcomes" Diagnostics 13, no. 6: 1094. https://doi.org/10.3390/diagnostics13061094

APA Style

Carmon, D., Rohana, H., Azrad, M., & Peretz, A. (2023). The Impact of a Positive Biofire® FilmArray® Gastrointestinal Panel Result on Clinical Management and Outcomes. Diagnostics, 13(6), 1094. https://doi.org/10.3390/diagnostics13061094

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop